Those adjustments just keep coming. As SFGATE reported, Genentech announced 436 layoffs in April 2024, and 93 more layoffs ...

Shigella vaccine candidate, altSonflex1-2-3 has shown encouraging results in the first stage of clinical trials ...

Bharat Biotech to advance development of GSK's Shigella vaccine candidate for severe bacterial diarrhoea: Our Bureau, Bengaluru Thursday, June 12, 2025, 15:30 Hrs [IST] Bharat Bio ...

Hyderabad: Bharat Biotech International Limited has announced that it has partnered with GSK plc for the ongoing development and potential use of the Shigella vaccine candidate, ...

Bharat Biotech has partnered with GSK to advance the Shigella vaccine altSonflex1-2-3. With strong early trial results and no ...

Data from the ongoing Phase 2a study shows a 100% disease control rate with 45% of patients with advanced cutaneous T-cell lymphoma achieving an objective response:One complete response, three partial ...

Bharat Biotech joins GSK to develop a Shigella vaccine to fight shigellosis in children, with Phase 3 trials underway and ...

Fapon Biopharma, a clinical-stage biotech company innovating therapeutic antibodies and fusion proteins, is pleased ...

Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Rocket Pharmaceuticals, Inc. securities between February 7, 2025 and May 26, ...

A Rockville biotech just struck a deal with Canadian asset management firm Sagard that will funnel the local company crucial ...

For decades, vaccines have been seen as tools to prevent disease, protecting us from measles, flu, and even certain types of ...

The startup, which is backed by the venture arms of Sanofi, Roche and Novartis, is using dual adeno-associated viruses to ...